Content provided by APO Group. CNBC Africa provides content from APO Group as a service to its readers and does not edit the articles it publishes. CNBC Africa is not responsible for the content provided by APO Group.
The Board of Directors of the African Development Bank (www.AfDB.org) has approved a $430,000 grant to Guinea to fight the spread of the Ebola hemorrhagic fever epidemic throughout the country.
Since mid-February 2021, Guinea has been facing a resurgent Ebola-related epidemic, following the major crisis of 2014. This new epidemic comes against the backdrop of the Covid-19 pandemic, which poses both health and socio-economic challenges to the West African country. The project was approved on 3 June.
The funding from the African Development Bank will enable Guinea to strengthen the diagnostic and sample management capacity of six regional laboratories. These laboratories will receive sample collection kits, reagents, and infection prevention and control equipment. Four regional laboratories will also receive GeneXPert equipment and genome sequencers, and biologists will be trained in Ebola virus diagnosis.
The project will also provide personal protective equipment and triage, isolation and case management facilities. In total, some 200 pieces of personal protective equipment will be distributed, including to health and community workers. Some 400 health workers and community volunteers will receive refresher training in infection prevention and case management, including survivors, in the affected regions.
The project responds to one of the African Development Bank’s High 5 strategic priorities, namely, Improving the quality of life of African people.
Distributed by APO Group on behalf of African Development Bank Group (AfDB).
Romaric Ollo Hien
Communication and External Relations Department
African Development Bank